Earnings · China A-shares
Hybio Pharmaceutical Co., Ltd. Class A (300199) earnings
Hybio Pharmaceutical Co., Ltd. Class A published its Q3 report on 2026-10-26: net profit +511.96% year on year, +741.83% excluding one-off items. Wave Radar's earnings-quality score is 100 of 100 (Sound). The stock moved -8.72% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-26
- Period end
- 2026-09-30
- Net profit YoY
- +511.96%
- Excl. one-offs YoY
- +741.83%
- Net profit QoQ
- +83.62%
- Result
- Great
- Quality score
- 100
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | -5.07% | — |
| 3 days | -8.72% | — |
| 7 days | -7.08% | — |
| 14 days | -6.75% | — |
Report history
Over the last 8 reports, net profit grew year on year in 8 of them. The stock rose in the 3 trading days after 0 of 6 reports (average -5.36%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-27 | ¥436.64M | +511.96% | +741.83% | +81.87% | 0.49 | 52.19% | -8.72% | — | — |
| 2026 interim report | 2026-08-21 | ¥236.70M | +62.72% | +85.90% | +25.27% | 0.27 | 32.33% | -2.57% | -1.62% | +4.08% |
| 2026 Q1 report | 2026-04-29 | ¥127.81M | +82.94% | +88.91% | -3.49% | 0.14 | 18.86% | -5.38% | -1.09% | -2.03% |
| 2025 annual report | 2026-04-29 | ¥36.57M | +121.06% | +105.76% | +63.73% | 0.04 | 6.13% | -5.38% | -1.09% | -2.03% |
| 2025 Q3 report | 2025-10-30 | ¥71.35M | +305.00% | +154.32% | +82.06% | 0.08 | 11.62% | -0.85% | -15.21% | -10.46% |
| 2025 interim report | 2025-08-22 | ¥145.47M | +1504.30% | +306.59% | +114.86% | 0.16 | 22.34% | -9.08% | -29.52% | -37.31% |
| 2025 Q1 report | 2025-04-26 | ¥69.87M | +595.45% | +507.78% | +106.29% | 0.08 | 11.39% | -5.55% | +17.26% | +14.02% |
| 2024 annual report | 2025-04-26 | -¥173.65M | +66.21% | +59.44% | +36.82% | -0.20 | -26.02% | -5.55% | +17.26% | +14.02% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.